
Bioniq Secures $15 Million Series B to Revolutionize Personalized Supplements Market
Bioniq, a trailblazer in AI-driven personalized supplements tailored to individual health needs, has successfully closed a $15 million Series B funding round. Led by prominent European VCs HV Capital and Unbound, this funding underscores Bioniq’s commitment to disrupting the one-size-fits-all approach prevalent in the dietary supplements industry. The company, valued at $75 million post-funding, plans…